Novel Hydroxysteroid (17β) Dehydrogenase 1 Inhibitors Reverse Estrogen-Induced Endometrial Hyperplasia in Transgenic Mice
- 1 March 2010
- journal article
- Published by Elsevier in The American Journal of Pathology
- Vol. 176 (3) , 1443-1451
Abstract
No abstract availableKeywords
Funding Information
- Suomen Kulttuurirahasto
- Research Council of Finland (211480, 121527, 77920)
- Sigrid Juséliuksen Säätiö
This publication has 70 references indexed in Scilit:
- Aberrant pre-receptor regulation of estrogen and progesterone action in endometrial cancerMolecular and Cellular Endocrinology, 2009
- Human HSD17B1 expression masculinizes transgenic female miceMolecular and Cellular Endocrinology, 2009
- Integrated view on 17beta-hydroxysteroid dehydrogenasesMolecular and Cellular Endocrinology, 2009
- Intratumoral concentration of sex steroids and expression of sex steroid-producing enzymes in ductal carcinoma in situ of human breastEndocrine-Related Cancer, 2008
- Amplification of HSD17B1 has prognostic significance in postmenopausal breast cancerBreast Cancer Research and Treatment, 2007
- AKR1C1 and AKR1C3 may determine progesterone and estrogen ratios in endometrial cancerMolecular and Cellular Endocrinology, 2006
- A woman's prerogativeNature Neuroscience, 2005
- Production, purification, and functional analysis of recombinant human and mouse 17β-hydroxysteroid dehydrogenase type 7Biochemical and Biophysical Research Communications, 2003
- Case--Control Study of Endogenous Steroid Hormones and Endometrial CancerJNCI: Journal of the National Cancer Institute, 1996
- Immunological measurement of human 17β-hydroxysteroid dehydrogenaseThe Journal of Steroid Biochemistry and Molecular Biology, 1990